Holen Sie sich die Stockscreener-App
0.3238
2.76%
0.0087
Vorhandelsmarkt:
.32
-0.0038
-1.17%
Bioatla Inc Aktie (BCAB) Neueste Nachrichten
BioAtla stock holds $1 target, Market Outperform rating By Investing.com - Investing.com India
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Norges Bank Makes New Investment in BioAtla, Inc. (NASDAQ:BCAB) - Defense World
BioAtla's SWOT analysis: oncology biotech's stock faces pivotal year - Investing.com
BioAtla’s SWOT analysis: oncology biotech’s stock faces pivotal year By Investing.com - Investing.com South Africa
BioAtla’s SWOT analysis: oncology biotech’s stock faces pivotal year - Investing.com India
HC Wainwright Has Optimistic Outlook of BioAtla Q1 Earnings - Defense World
FY2029 Earnings Estimate for BioAtla Issued By HC Wainwright - Defense World
BioAtla (NASDAQ:BCAB) Given “Neutral” Rating at HC Wainwright - Defense World
BioAtla stock price target cut to $1 by Citizens JMP - Investing.com Australia
Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace
BioAtla price target lowered to $1 from $5 at Citizens JMP - TipRanks
BioAtla, Inc. (NASDAQ:BCAB) Q4 2024 Earnings Call Transcript - MSN
Companies Like BioAtla (NASDAQ:BCAB) Could Be Quite Risky - Yahoo Finance
BioAtla’s Earnings Call: Clinical Progress and Strategic Outlook - TipRanks
BioAtla stock price target cut to $10 at BTIG, retains Buy rating - Investing.com Canada
BioAtla stock price target cut to $10 at BTIG, retains Buy rating By Investing.com - Investing.com South Africa
BioAtla Inc. (BCAB) reports earnings - Quartz
BioAtla, Inc. SEC 10-K Report - TradingView
BioAtla, Inc. Reports 2024 Financial Results and Clinical Progress - TipRanks
Earnings call transcript: BioAtla Q4 2024 sees strategic cost cuts, stock rises By Investing.com - Investing.com South Africa
Earnings call transcript: BioAtla Q4 2024 sees strategic cost cuts, stock rises - Investing.com India
BioAtla announces restructuring, to cut over 30% of workforce - TipRanks
BioAtla reports Q4 Net loss ($14.9M) vs ($26.9M) last year - TipRanks
Bioatla IncAnnounces 30% Workforce Reduction - MarketScreener
BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress - The Manila Times
Earnings Outlook For BioAtla - Benzinga
BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings - Quantisnow
BioAtla, Inc. Announces Abstract Presentations at European Lung Cancer Congress and Mayo Clinic Symposium 2025 - Nasdaq
BioAtla Advances Cancer Research with Dual Presentations at Elite European and Mayo Clinic Conferences - Stock Titan
BioAtla to Announce Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Highlights on March 27, 2025 - Quantisnow
BioAtla (BCAB) Expected to Announce Quarterly Earnings on Tuesday - Defense World
BioAtla Awards Executive Bonuses and Stock Units - TipRanks
What Are You Thinking About Investing In BioAtla Inc (NASDAQ: BCAB) Stock? - stocksregister.com
BioAtla, Inc. (NASDAQ:BCAB) Short Interest Down 12.6% in February - Defense World
Bioatla stock hits 52-week low at $0.38 amid sharp decline By Investing.com - Investing.com South Africa
Bioatla stock hits 52-week low at $0.38 amid sharp decline - Investing.com UK
BioAtla Inc (BCAB) shows promising results - US Post News
Market Momentum Report: BioAtla Inc (BCAB)’s Negative Close at 0.45 - The Dwinnex
BioAtla Inc: Navigating a Turbulent Year, Up -88.84% from 52-Week Low - The InvestChronicle
2.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):